Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             40 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia Song, Juanjuan

103 2 p. 463-473
artikel
2 Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients Casale, Maddalena

103 2 p. 623-629
artikel
3 A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation Dang, E.

103 2 p. 631-643
artikel
4 Analysis of PROC mutations and clinical features in 22 unrelated families with inherited protein C deficiency Xu, Fei

103 2 p. 645-652
artikel
5 Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency Xu, Fei

103 2 p. 653-662
artikel
6 A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan Horigome, Yuichi

103 2 p. 475-488
artikel
7 BRCA2 germline mutation in familial leukaemia with familial breast cancer: a case report Wang, Jing

103 2 p. 685-687
artikel
8 CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients Wang, Tao

103 2 p. 575-582
artikel
9 Clinical characteristics of hepatitis-associated aplastic anemia in children Fu, Lingling

103 2 p. 397-404
artikel
10 Cold agglutinin–induced acrocyanosis without hemolytic anemia Kitamura, Wataru

103 2 p. 681-683
artikel
11 Comment on: Association between anemia and depression: results from NHANES 2005–2018 and Mendelian randomization analyses Si, Tianyu

103 2 p. 689-691
artikel
12 Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis Li, Na

103 2 p. 693-694
artikel
13 Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience Tosoni, Luca

103 2 p. 449
artikel
14 Correction to: Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi‑center registry Songdej, Duantida

103 2 p. 395
artikel
15 Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience Tosoni, Luca

103 2 p. 443-448
artikel
16 Detection and quantification of JAK2V617F copy number by droplet digital PCR versus real-time PCR Wu, Sanyun

103 2 p. 421-426
artikel
17 Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect Delgadinho, Mariana

103 2 p. 409-419
artikel
18 Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study Zhao, Danqing

103 2 p. 545-552
artikel
19 Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia Hussan, Syeda Saliah

103 2 p. 511-523
artikel
20 Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia—a national inpatient sample analysis Savani, Saloni

103 2 p. 663-665
artikel
21 Feasibility of allogeneic hematopoietic stem cell transplantation in advanced age Fernandez-Luis, Sara

103 2 p. 583-591
artikel
22 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas Shen, Hao-Rui

103 2 p. 565-574
artikel
23 Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study Brusosa, Marc

103 2 p. 609-621
artikel
24 Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience Sobas, Marta

103 2 p. 451-461
artikel
25 In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation Brunner, Andrea

103 2 p. 553-563
artikel
26 Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement Tan, Lennart

103 2 p. 667-669
artikel
27 Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome–negative acute lymphoblastic leukemia Fischer, Daniel

103 2 p. 489-498
artikel
28 Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival García-Morin, Marina

103 2 p. 373-383
artikel
29 Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry Songdej, Duantida

103 2 p. 385-393
artikel
30 Myeloablative or reduced-intensity/non-myeloablative hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in adults older than 40 years old — a secondary analysis of a CIBMTR database de Oliveira Fernandes Junior, Irtis

103 2 p. 603-607
artikel
31 Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine Lucijanic, Marko

103 2 p. 671-672
artikel
32 Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease Rees, Matthew J.

103 2 p. 593-602
artikel
33 Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia chromosome–positive acute lymphoblastic leukemia: two-case report Fan, Shengxuan

103 2 p. 525-532
artikel
34 Pulmonary Erdheim-Chester disease successfully treated with vemurafenib Shen, Kai-ni

103 2 p. 673-675
artikel
35 Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes Barbui, Tiziano

103 2 p. 437-442
artikel
36 Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia Pope, Victor

103 2 p. 677-679
artikel
37 Successful treatment with oseltamivir phosphate in children with ITP who failed first-line therapy: a case series report Liu, Li-ya

103 2 p. 405-408
artikel
38 The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib Mulas, Olga

103 2 p. 427-436
artikel
39 USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by inhibiting STUB1-induced NFAT5 ubiquitination Chen, Beili

103 2 p. 533-544
artikel
40 Zanubrutinib-lenalidomide-rituximab (ZR2) in unfit diffuse large B-cell lymphoma: efficient and tolerant Wang, Yawen

103 2 p. 499-510
artikel
                             40 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland